AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2026 Issue 1; Section 3 – Administration
Introduction of Embryonic Stem Cells
In table 3E0, Introduction of Physiological Systems and Anatomical Regions, substance value A Embryonic Stem Cells, was added to body system/region values 3 Peripheral Vein, and 4 Central Vein, for the approach value 3 Percutaneous. This addition creates codes to describe the venous introduction of embryonic stem cells.Body System/Region Approach Substance Qualifier 3 Peripheral Vein 4 Central Vein 3 Percutaneous A Stem Cells, Embryonic Z No Qualifier Embryonic stem cells are derived from the inner cell mass of a blastocyst of an early stage embryo. They have the ability to divide into more stem cells or differentiate into...
Subscribe or sign in to view the full article.
Article Overview
This article covers an ICD-10-PCS update involving embryonic stem cells, including where the substance value was added and where it was removed from the code tables. It is relevant to hospital coders, CDI professionals, and reimbursement teams tracking annual code set revisions and code validity changes.
Why This Topic Matters
Understanding this update helps readers stay current with ICD-10-PCS table changes and code status revisions affecting documentation review and procedure coding in inpatient settings.
What You Will Learn
- How the article frames the ICD-10-PCS table update involving embryonic stem cells.
- Which code table area received the new substance value and which table area lost it.
- How the article positions the change in relation to venous procedure coding.
- What it means for keeping procedure code references current after code set updates.
Who Should Read This
- Inpatient medical coders
- Clinical documentation integrity specialists
- Revenue cycle professionals
- Coding auditors
- Healthcare compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com